152 Pediatric Grand Rounds: “Fibroblast Growth Factor 23 (FGF23): A Friend, Foe or a Mere Biomarker” (012622)

Dallas, TX US
January 26, 2022

This program is designed to provide an ongoing forum to obtain information about new developments in pediatrics utilizing lectures, slides and a Q&A format.

Target Audience

Practicing Physicians, including Children’s Medical Center Staff, UT Southwestern faculty and community physicians.

Learning Objectives

1. Partipants will understand how the Human Microbiome Project is changing our view of airway infection in CF
2. Participants will better understand the impact of antibiotic management on the lung microbiome in CF

Course summary
Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
01/26/2022
Course expires: 
01/26/2022
Event starts: 
01/26/2022 - 8:00am CST
Event ends: 
01/26/2022 - 9:00am CST
Cost:
$0.00
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Moore Auditorium
Dallas, TX 75390
United States
Committee member(s)

Rana Said

has no relevant financial relationships to disclose at this time.

Mary Villani, MD

has no relevant financial relationships to disclose at this time.

Matthias Wolf

has no relevant financial relationships to disclose at this time.
Course Director(s)

Jeffrey Kahn

has a financial relationship (Financial Stake) with Avsana Labs;.
Speaker(s)

Jyothsna Gattineni, MD

has no relevant financial relationships to disclose at this time.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.